Astrocytes facilitate melanoma brain metastasis via secretion of IL-23

Journal of Pathology

Volumn 236, Issue 1, 2015, Pages 116-127

  Klein, Anat ^a   Schwartz, Hila ^a   Sagi Assif, Orit ^a   Meshel, Tsipi ^a   Izraely, Sivan ^a   Ben Menachem, Shlomit ^a   Bengaiev, Roman ^a   Ben Shmuel, Amir ^a   Nahmias, Clara ^b   Couraud, Pierre Olivier ^b   Witz, Isaac P ^a   Erez, Neta ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUT COCHIN   (France)

Author keywords

astrocytes; brain metastasis; IL 23; melanoma; microenvironment; neuroinflammation

Indexed keywords

GELATINASE A; INTERLEUKIN 23; NEUTRALIZING ANTIBODY; MMP2 PROTEIN, HUMAN; MMP2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN METASTASIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BRAIN TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; SKIN TUMOR; UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; HUMANS; INTERLEUKIN-23; MALE; MATRIX METALLOPROTEINASE 2; MELANOMA; MICE, NUDE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; UP-REGULATION;

EID: 84927689875     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4509     Document Type: Article

References (50)

1. Jerant AF, Johnson JT, Sheridan CD, et al., Early detection and treatment of skin cancer. Am Fam Physician 2000; 62: 357-368, 375-376, 381-382.
2. Sloan AE, Nock CJ, Einstein DB,. Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 2009; 16: 248-255.
3. Erez N, Coussens LM,. Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer 2011; 128: 2536-2544.
4. Joyce JA, Pollard JW,. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252.
5. Klein-Goldberg A, Maman S, Witz IP,. The role played by the microenvironment in site-specific metastasis. Cancer Lett 2014; 352: 54-58.
6. Langley RR, Fan D, Guo L, et al., Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. Int J Oncol 2009; 35: 665-672.
7. Fidler IJ, Balasubramanian K, Lin Q, et al., The brain microenvironment and cancer metastasis. Mol Cell 2010; 30: 93-98.
8. Izraely S, Sagi-Assif O, Klein A, et al., The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer 2012; 131: 1071-1082.
9. Farina C, Aloisi F, Meinl E,. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28: 138-145.
10. Marchetti B, Abbracchio MP,. To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy of neurodegenerative disorders' Trends Pharmacol Sci 2005; 26: 517-525.
11. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
12. Klein A, Sagi-Assif O, Izraely S, et al., The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells. Int J Cancer 2012; 131: 2509-2518.
13. Croxford AL, Mair F, Becher B,. IL-23: one cytokine in control of autoimmunity. Eur J Immunol 2012; 42: 2263-2273.
14. Weksler BB, Subileau EA, Perriere N, et al., Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872-1874.
15. Izraely S, Sagi-Assif O, Klein A, et al., The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int J Cancer 2015; 136: 1296-1307.
16. Miltenyi S, Muller W, Weichel W, et al., High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
17. Nevo I, Sagi-Assif O, Edry Botzer L, et al., Generation and characterization of novel local and metastatic human neuroblastoma variants. Neoplasia 2008; 10: 816-827.
18. Nicolson GL,. Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers. J Histochem Cytochem 1982; 30: 214-220.
19. Ballabh P, Braun A, Nedergaard M,. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13.
20. Calingasan NY, Erdely HA, Altar CA,. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol Aging 2002; 23: 31-39.
21. Hu XM, Liu YN, Zhang HL, et al., CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J Neurochem 2014; DOI: 10.1111/jnc.12985.
22. Kim DY, Hong GU, Ro JY,. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation 2011; 8: 25.
23. Tuttolomondo A, Di Raimondo D, di Sciacca R, et al., Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 2008; 14: 3574-3589.
24. Wang X, Suzuki Y,. Microglia produce IFN-γ independently from T cells during acute toxoplasmosis in the brain. J Interferon Cytokine Res 2007; 27: 599-605.
25. Lv M, Liu Y, Zhang J, et al., Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury. Neuroscience 2011; 176: 162-172.
26. Steinman L., A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009; 9: 440-447.
27. Langowski JL, Zhang X, Wu L, et al., IL-23 promotes tumour incidence and growth. Nature 2006; 442: 461-465.
28. Shichita T, Sakaguchi R, Suzuki M, et al., Post-ischemic inflammation in the brain. Front Immunol 2012; 3: 132.
29. Vom Berg J, Prokop S, Miller KR, et al., Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat Med 2012; 18: 1812-1819.
30. Kessenbrock K, Plaks V, Werb Z,. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
31. Redondo P, Lloret P, Idoate M, et al., Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol 2005; 30: 541-545.
32. Maman S, Witz IP,. The Metastatic Microenvironment. In The Tumor Microenvironment, Shurin MR, Umansky V, Malyguine A, (eds). Springer: Dordrecht, 2013; 15-38.
33. Fitzgerald DP, Palmieri D, Hua E, et al., Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metast 2008; 25: 799-810.
34. Noda M, Seike T, Fujita K, et al., The role of immune cells in brain metastasis of lung cancer cells and neuron-tumor cell interaction. Ross Fiziol Zh Im I M Sechenova 2009; 95: 1386-1396.
35. Seike T, Fujita K, Yamakawa Y, et al., Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metast 2011; 28: 13-25.
36. Fidler IJ,. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 2011; 21: 107-112.
37. Kim SJ, Kim JS, Park ES, et al., Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 2011; 13: 286-298.
38. Kim SW, Choi HJ, Lee HJ, et al., Role of the endothelin axis in astrocyte-and endothelial cell-mediated chemoprotection of cancer cells. Neuro Oncol 2014; 16: 1585-1598.
39. Kamiya T, Mobley AK, Bar-Eli M,. Crossing the junction in the gap of melanoma brain metastasis. Pigment Cell Melanoma Res 2013; 26: 435-437.
40. Lin Q, Balasubramanian K, Fan D, et al., Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia 2010; 12: 748-754.
41. D'Elios MM, Del Prete G, Amedei A,. Targeting IL-23 in human diseases. Expert Opin Ther Targets 2010; 14: 759-774.
42. Constantinescu CS, Tani M, Ransohoff RM, et al., Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J Neurochem 2005; 95: 331-340.
43. Wight RD, Tull CA, Deel MW, et al., Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem Biophys Res Commun 2012; 426: 112-115.
44. von Scheidt B, Leung PS, Yong MC, et al., Combined anti-CD40 and anti-IL-23 monoclonal antibody therapy effectively suppresses tumor growth and metastases. Cancer Res 2014; 74: 2412-2421.
45. Hofmann UB, Westphal JR, Waas ET, et al., Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 1999; 81: 774-782.
46. Rotte A, Martinka M, Li G,. MMP2 expression is a prognostic marker for primary melanoma patients. Cell Oncol (Dordr) 2012; 35: 207-216.
47. Wang L, Cossette SM, Rarick KR, et al., Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS One 2013; 8: e80933.
48. Coussens LM, Tinkle CL, Hanahan D, et al., MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-490.
49. Jodele S, Blavier L, Yoon JM, et al., Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metast Rev 2006; 25: 35-43.
50. Valiente M, Obenauf AC, Jin X, et al., Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014; 156: 1002-1016.